Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pío del Río Hortega and the discovery of the oligodendrocytes.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells.
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model.
A case of simultaneous neuromyelitis optica spectrum disorder and subacute combined degeneration.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Optical coherence tomography should be part of the routine monitoring of patients with multiple sclerosis: Commentary.
Detection of olfactory dysfunction using olfactory event related potentials in young patients with multiple sclerosis.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
What is the Real Fate of Vitamin D in Multiple Sclerosis?
Electrophysiological Evaluation of Dysphagia in the Mild or Moderate Patients with Multiple Sclerosis: A Concept of Subclinical Dysphagia.
Rapid dissemination of granular cell astrocytoma arising from periventricular stem cell regions in chronic multiple sclerosis.
Widespread Pressure Pain Hypersensitivity in Patients with Multiple Sclerosis with and Without Pain as Sign of Central Sensitization.
An adult case of multiphasic disseminated encephalomyelitis manifesting with optic neuritis.
What's in the Literature?
Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis.
OCT: New perspectives in neuro-ophthalmology.
An ex-vivo multiple sclerosis model of inflammatory demyelination using hyperbranched polymer.
Epigenetic in Multiple Sclerosis: Molecular mechanisms and dietary intervention.
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
[Assessment of the size of the thalamus as a method for the evaluation of the activity of neurodegenerative process after the treatment with cerebrolisin in young patients with multiple sclerosis.]
Application of q-Space Diffusion MRI for the Visualization of White Matter.
Development of a crosswalk for pain interference measured by the BPI and PROMIS pain interference short form.
Mir-155 as a multiple sclerosis-relevant regulator of myeloid cell polarization.
Pages
« first
‹ previous
…
516
517
518
519
520
521
522
523
524
…
next ›
last »